Arpida remains confident in the efficacy and safety of intravenous iclaprim and its potential in combating serious resistant infections.
121366
Arpida remain confident about iclaprim
128394
Two new drugs can slash stroke risk
37199
Bionovo (bnvi) to present positive results from phase 2 trial of Menerba
175676
Most 'locked-in syndrome' patients are happy
5056
Recovery program 'progressing steadily'
164021
Current protease inhibitor use does not increase risk of stroke or sudden death
64651
Anti-depressants may act as potential saviours against HIV/AIDS
171046
Ivermectin kills head lice resistant to standard treatments
99260
Lynas says it's committed to operating in safe manner
129056
Merck achieves positive results in Phase 3 trials of insomnia drug
132441
Pulmatrix launches iSPERSE, a novel inhaled dry powder drug delivery platform
28459
Verekauta keeps fingers crossed
81661
Scientists develop safer and more accurate way to administer warfarin
57802
Pepscan achieves a breakthrough with CLIPS immunogen technology:
102235
Medicine prices have yet to go down --
149265
It, pharma continue to look good:
81467
Nelson Mandela 'responding positively' to hospital treatment for recurring lung infection